Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Iqvia Holdings Inc (IQV)

Iqvia Holdings Inc (IQV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,124,920
  • Shares Outstanding, K 182,200
  • Annual Sales, $ 14,984 M
  • Annual Income, $ 1,358 M
  • EBIT $ 3,154 M
  • EBITDA $ 4,297 M
  • 60-Month Beta 1.49
  • Price/Sales 2.85
  • Price/Cash Flow 14.86
  • Price/Book 6.35

Options Overview Details

View History
  • Implied Volatility 36.85% ( +1.51%)
  • Historical Volatility 20.90%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 36.85% on 10/21/24
  • IV Low 20.55% on 03/20/24
  • Put/Call Vol Ratio 2.03
  • Today's Volume 354
  • Volume Avg (30-Day) 661
  • Put/Call OI Ratio 1.68
  • Today's Open Interest 7,856
  • Open Int (30-Day) 8,855

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 2.57
  • Number of Estimates 7
  • High Estimate 2.60
  • Low Estimate 2.50
  • Prior Year 2.29
  • Growth Rate Est. (year over year) +12.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
224.41 +3.02%
on 10/07/24
245.20 -5.71%
on 09/23/24
-10.93 (-4.51%)
since 09/20/24
3-Month
224.41 +3.02%
on 10/07/24
252.88 -8.58%
on 08/29/24
+6.62 (+2.95%)
since 07/19/24
52-Week
167.42 +38.09%
on 11/01/23
261.73 -11.67%
on 03/08/24
+46.83 (+25.40%)
since 10/20/23

Most Recent Stories

More News
IQVIA Holdings' Quarterly Earnings Preview: What You Need to Know

With IQVIA Holdings gearing up to release its third-quarter earnings later this month, analysts project a double-digit surge in earnings.

XLV : 151.33 (-1.18%)
$SPX : 5,853.98 (-0.18%)
IQV : 231.19 (-2.32%)
EPAM Expands With First Derivative Buyout: What Should Investors Do?

EPAM Systems EPAM has seen its share price plunge 35.3% year to date, underperforming the Zacks Computers - IT Services industry, Zacks Computer and Technology sector and the S&P 500’s return of 8.4%,...

MSFT : 418.78 (+0.15%)
EPAM : 199.98 (-0.79%)
CRM : 291.29 (-0.56%)
IQV : 231.19 (-2.32%)
Here's Why You Should Retain IQVIA Holdings Shares Now

IQVIA Holdings Inc. IQV has had an impressive run over the past three months. The stock has gained 9.3%, outperforming the 3.9% rise of the industry it belongs to and the Zacks S&P 500 composite’s 2%...

APP : 158.85 (+9.39%)
DOCU : 71.78 (-0.72%)
IQV : 231.19 (-2.32%)
Is Viking Therapeutics Stock a Buy?

The company is in the spotlight for one of its programs, but it's got others that also have promise.

VKTX : 64.34 (-2.22%)
LLY : 906.13 (-1.29%)
IQV : 231.19 (-2.32%)
Is Charles River Laboratories Stock Underperforming the Dow?

Charles River Laboratories underperformed the Dow recently, but Wall Street analysts remain moderately optimistic about the stock’s prospects.

$DOWI : 42,931.60 (-0.80%)
CRL : 195.04 (-1.38%)
IQV : 231.19 (-2.32%)
Is IQVIA Holdings Stock Underperforming the S&P 500?

Despite IQVIA Holdings’ underperformance compared to the S&P 500 Index over the past year, Wall Street analysts remain optimistic about the stock’s prospects.

IQV : 231.19 (-2.32%)
$SPX : 5,853.98 (-0.18%)
A : 136.76 (-1.49%)
IQVIA Holdings Stock Outlook: Is Wall Street Bullish or Bearish?

IQVIA Holdings has underperformed the broader market this year, but Wall Street analysts are bullish about the stock’s prospects.

IQV : 231.19 (-2.32%)
$SPX : 5,853.98 (-0.18%)
XLV : 151.33 (-1.18%)
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:EXAI),(NASDAQ:TWST),(NYSE:IQV) EQNX::TICKER_END

AVAI : 0.2970 (-5.11%)
RXRX : 6.76 (-2.59%)
EXAI : 5.09 (-2.30%)
TWST : 45.35 (-3.37%)
IQV : 231.19 (-2.32%)
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates

AVAI : 0.2970 (-5.11%)
RXRX : 6.76 (-2.59%)
EXAI : 5.09 (-2.30%)
TWST : 45.35 (-3.37%)
IQV : 231.19 (-2.32%)
Stock Index Futures Tread Water as Investors Await Tesla and Alphabet Earnings

September S&P 500 E-Mini futures (ESU24) are up +0.02%, and September Nasdaq 100 E-Mini futures (NQU24) are down -0.11% this morning as investor attention shifted from U.S. politics to a deluge of corporate...

ESU24 : 5,699.99s (-0.31%)
NQU24 : 19,808.01s (-0.21%)
IQV : 231.19 (-2.32%)
ON : 67.14 (-1.97%)
NVDA : 143.71 (+4.14%)
CRWD : 309.55 (-0.19%)
VZ : 43.70 (-0.66%)
GOOGL : 164.07 (+0.40%)
TSLA : 218.85 (-0.84%)
V : 286.85 (-1.30%)
KO : 69.45 (-1.41%)
PM : 118.96 (-1.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in...

See More

Key Turning Points

3rd Resistance Point 239.45
2nd Resistance Point 237.38
1st Resistance Point 234.29
Last Price 231.19
1st Support Level 229.13
2nd Support Level 227.06
3rd Support Level 223.97

See More

52-Week High 261.73
Last Price 231.19
Fibonacci 61.8% 225.70
Fibonacci 50% 214.58
Fibonacci 38.2% 203.45
52-Week Low 167.42

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar